Protective effect of Curcumin on chemotherapy-induced Intestinal dysfunction

来源 :2013中国医师协会中西医结合医师大会 | 被引量 : 0次 | 上传用户:lubin_1985
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Chemotherapy is one of most important treatment for human cancers.However, its side effects such as intestine dysfunction significantly impaired its clinical efficacy.This study was designed to investigate the protective effect of curcumin on chemotherapy-induced intestinal dysfunction in rats.Methods Sixty healthy Wistar rats were randomly divided into control group (normal saline), 5-FU group and 5-FU+curcumin group.The weight, endotoxin, DAO and D-lactate level were determined during the experiment.The pathological change of intestinal mucosa structure was studied under light microscopy and electron microscopy.The expression of Bax, Bcl-2 and Caspase-3 were assessed by immunohistochemical staining.Results The curcumin intragastrically administrated obviously reduced 5-FU-induced weight-loss.5-FU induced dramatic increase of serum endotoxin, D-lactate and D-AminoAcid Oxidase (DAO) that were significantly reversed by curcumin treatment.Meanwhile, 5-FU-induceddamage to intestinal mucosa structure was markedly recovered by curcumin.The expression of Bax and Caspase-3 were dramatically increased after 5-FU treatment (p<0.01) and curcumin treatment significantly reduced Bax expression (p<0.05) but had only a moderate effect on reducing caspase-3 expression (p>0.05).Interestingly, Bcl-2 expression was low in control group but increased after 5-FU treatment (p>0.05) and curcumin treatment further stimulated Bcl-2 expression (p<0.05).Conclusions Curcumin can significantly reverse chemotherapy-induced weight-loss, increase of serum endotoxin, D-lactate and DAO and damage to intestinal mucosa structure.Curcumin also reduced the expression of pro-apoptotic Bax but stimulated anti-apoptotic Bcl-2 to attenuate 5-FU-induced apoptosis of intestinal epithelial cells.The clinical administration of curcumin may improve chemotherapy-induced intestinal dysfunction, thus increasing the clinical efficacy of chemotherapy.
其他文献
目的 探讨补肾安神胶囊治疗癌症患者抑郁失眠症的临床观察。方法 56例符合标准的患者按就诊时间随机分为治疗组和对照组,治疗组采用补肾安神胶囊治疗,对照组采用百优解治疗,于治疗前、治疗后2、4、6、8周末采用汉密尔顿抑郁量表(HAMD17)评定疗效,及患者治疗前后失眠及伴随症状的改善情况。结果 两组患者在治疗后2周末、4周末、6周末、8周末可明显降低患者的HAMD评分,但两组间比较均无明显差异。在睡眠
目的 探讨黄芪桂枝五加物汤加减足浴对化疗后末梢神经炎的临床疗效.方法 将46例化疗后出现末梢神经炎的肿瘤患者随机分为两组.治疗组23例,采用足浴,足浴方以黄芪桂枝五物汤加减,每次浸泡30 min,每日浸泡一次,对照组为西药组23例,甲钴胺片0.5毫克日三次口服.治疗周期为2个月.结果 足浴组总有效率为91.3%,西药组总有效率为56.5%,经统计学处理,两组疗效有统计学意义(P<0.05).结论
目的 对使用华蟾素注射液治疗的肿瘤患者局部外敷木立芦荟,观察木立芦荟对华蟾素所致静脉炎预防的临床效果. 方法 选择肿瘤科应用同剂量华蟾素注射液静滴治疗的住院患者90例,随机分为金黄散组、芦荟组、生理盐水组,每组30例,分别在静脉穿刺点以上循行部位外用金黄散、木立芦荟、生理盐水,每日1次,每周观察1次,观察3周,比较三组每周静脉炎发生情况.结果 (1)在华蟾素治疗后的第一周时,芦荟组和生理盐水组的发
目的 探讨经后腹腔和腹腔联合的途径治疗肾脏肿瘤适应证的选择和治疗效果.方法 回顾分析2007年5月至2012年5月共58例经后腹腔和腹腔联合途径行肾脏手术,其中肾透明细胞癌肾部分切除48例,肾错构瘤肿瘤剜除术10例,右侧20例,左侧38例,肿瘤平均直径3.5 cm.全部病例健侧卧位,首先采用常规腰部的三个穿刺孔放入腹腔镜和分离器械,游离后腹腔空间及显露肾动脉然后,有意识地纵向切开和切除部分侧腹膜,
目的 观察肺泰胶囊治疗晚期非小细胞肺癌(non-small cell lung cancer NSCLC)的临床疗效,并探讨探讨该药对NF-κB信号转导通路的影响.方法 前期治疗结束且病情评价稳定的非小细胞肺癌患者60例,随机分为试验组、对照组.试验组口服肺泰胶囊4周;对照组同时间内不接受任何治疗.观察两组4周前后临床症状、生活质量、瘤体指标的改变,检测患者外周血中NF-κBp65、 IL-1β、
目的 探讨荧光原位杂交技术(FISH)在膀胱癌诊断中的临床应用价值.方法 收集2010年1月至2012年6月30例可疑膀胱尿路移行上皮细胞肿瘤的血尿患者的尿液标本,同时行尿脱落细胞学检测和荧光原位杂交分析.并与最终的病理学检查结果对比.结果 尿脱落细胞学的灵敏度为33.33%,特异度为:100%,FISH的灵敏度为85.71%,特异度为88.89%,两者灵敏度相比差异具有统计学意义(P<0.05)
Background Pancreatic cancer remains one of the leading causes of cancer-related deaths, due to aggressive growth, high metastatic rates during the early stage and the lack of an effective therapeutic
目的 讨论荧光原位杂交技术在预测膀胱癌复发中的临床应用价值.方法 对40例经病理检查证实的膀胱癌患者在肿瘤电切术后行FISH检测,研究膀胱癌患者FISH检测结果与肿瘤复发的关系.结果 FISH检测后平均随访1年,18例出现肿瘤复发,其中FISH为阳性者16例(88.89%),阴性者2例(11.11%);无肿瘤复发者22例,其中FISH为阳性者12例(54.54%),阴性者10例(45.45%).总
目的 建立大鼠Walker-256乳腺癌细胞胫骨骨癌痛模型,以身痛逐瘀汤进行干预,探讨身痛逐瘀汤对骨癌痛的镇痛作用及其可能的作用机制.方法 右后肢胫骨注射Walker-256乳腺癌细胞建立骨癌痛模型,实验分为三个部分.实验第一部分:取雌性SD大鼠32只,随机分成4组:假手术+生理盐水组、假手术+身痛逐瘀汤组、骨癌痛+生理盐水组、骨癌痛+身痛逐瘀组,每组8只.假手术+生理盐水组和骨癌痛+牛理盐水组在
Objective Omega-3 polyunsaturated fatty acids (n-3 PUFA), in particular the marine-derived forms eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been shown to influence cancer cell re